The Lmdd-MPFG vaccine is based on an attenuated strain of the Listeria bacterium, which has been modified to express a specific antigen called glypican-3 (GPC3), commonly found on the surface of HCC cells. The gene discussed is GPC3; the disease is hepatocellular carcinoma.